Auxilius Led
2 known investors
Auxilius provides software and expert services to manage clinical R&D operations and financial processes for biotech companies. The platform automates budgeting, forecasting, and financial close procedures to reduce clinical trial failures caused by operational complexity.
Founders & leadership
Investors · 2
.svg)
.jpeg){kind=logo}
Competitors · 3
by search overlap
Abacum11 shared keywordsAbacum is a financial planning and analysis (FP&A) platform designed for mid-market finance teams. The platform enables clients to manage planning models without requiring system administrators, supporting faster implementation and adoption across finance and broader organizational teams.
Globant11 shared keywordsGlobant is an IT and software engineering services company that builds AI-native and digital products for enterprise clients across industries including sports, automotive, media, and government. It offers an AI platform ("Glob.AI") with AI Pods and AI Studios to deliver production-ready software and reinvent customer experiences for large organizations.
Power10 shared keywordsPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
Companies competing with Auxilius Led for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Auxilius Led do?
- Auxilius provides software and expert services to manage clinical R&D operations and financial processes for biotech companies. The platform automates budgeting, forecasting, and financial close procedures to reduce clinical trial failures caused by operational complexity.
- Who founded Auxilius Led?
- Auxilius Led was founded by Adam Weisman, Erin Warner Guill.
- Who are Auxilius Led's investors?
- Auxilius Led's investors include Renegade Partners, Valspring Capital.